These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical evaluation of a novel bipolar radiofrequency ablation system for renal masses. Okhunov Z; Roy O; Duty B; Waingankar N; Herati A; Morgenstern N; Sheikh-Fayyaz S; Kavoussi LR BJU Int; 2012 Sep; 110(5):688-91. PubMed ID: 22394594 [TBL] [Abstract][Full Text] [Related]
8. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up. Forauer AR; Dewey BJ; Seigne JD Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958 [TBL] [Abstract][Full Text] [Related]
9. Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours: midterm results. Fotiadis NI; Sabharwal T; Morales JP; Hodgson DJ; O'Brien TS; Adam A Eur Urol; 2007 Sep; 52(3):777-84. PubMed ID: 17400364 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Rossi S; Dore R; Cascina A; Vespro V; Garbagnati F; Rosa L; Ravetta V; Azzaretti A; Di Tolla P; Orlandoni G; Pozzi E Eur Respir J; 2006 Mar; 27(3):556-63. PubMed ID: 16507856 [TBL] [Abstract][Full Text] [Related]
11. Extending the survival of patients with melanoma lung metastases through radiofrequency ablation. Chua TC; Glenn D; Morris DL Acta Oncol; 2010 May; 49(4):517-9. PubMed ID: 20100162 [No Abstract] [Full Text] [Related]
12. The efficacy of bipolar and multipolar radiofrequency ablation of lung neoplasms - results of an ablate and resect study. Schneider T; Reuss D; Warth A; Schnabel PA; von Deimling A; Herth FJ; Dienemann H; Hoffmann H Eur J Cardiothorac Surg; 2011 Jun; 39(6):968-73. PubMed ID: 20961771 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment? Carrafiello G; LaganĂ D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients. Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors. Thanos L; Mylona S; Pomoni M; Athanassiadi K; Theakos N; Zoganas L; Batakis N Eur J Cardiothorac Surg; 2006 Nov; 30(5):797-800. PubMed ID: 17000115 [TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors. Yang Q; Qi H; Zhang R; Wan C; Song Z; Zhang L; Fan W J Vasc Interv Radiol; 2017 Apr; 28(4):481-489. PubMed ID: 28111196 [TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Suh R; Reckamp K; Zeidler M; Cameron R Oncology (Williston Park); 2005 Oct; 19(11 Suppl 4):12-21. PubMed ID: 16366374 [TBL] [Abstract][Full Text] [Related]